Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2016 1
2020 2
2021 1
2022 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
LRRK2 Phosphorylation, More Than an Epiphenomenon.
Marchand A, Drouyer M, Sarchione A, Chartier-Harlin MC, Taymans JM. Marchand A, et al. Front Neurosci. 2020 Jun 16;14:527. doi: 10.3389/fnins.2020.00527. eCollection 2020. Front Neurosci. 2020. PMID: 32612495 Free PMC article. Review.
Alpha-Synuclein and Lipids: The Elephant in the Room?
Sarchione A, Marchand A, Taymans JM, Chartier-Harlin MC. Sarchione A, et al. Among authors: marchand a. Cells. 2021 Sep 17;10(9):2452. doi: 10.3390/cells10092452. Cells. 2021. PMID: 34572099 Free PMC article. Review.
Skin toxicity of enfortumab vedotin: Proposal of a specific management algorithm.
Ingen-Housz-Oro S, Elshot YS, Segura S, Marchand A, Pouessel D, Kluger N, de Barros Silva G, Ortiz-Brugues A, Aubert M, Saldana C, Mavroudis D, Burle E, Tournier E, Koumaki D, Sibaud V. Ingen-Housz-Oro S, et al. Among authors: marchand a. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e99-e101. doi: 10.1111/jdv.19454. Epub 2023 Aug 29. J Eur Acad Dermatol Venereol. 2024. PMID: 37607297 No abstract available.
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease.
Coku I, Mutez E, Eddarkaoui S, Carrier S, Marchand A, Deldycke C, Goveas L, Baille G, Tir M, Magnez R, Thuru X, Vermeersch G, Vandenberghe W, Buée L, Defebvre L, Sablonnière B, Chartier-Harlin MC, Taymans JM, Huin V. Coku I, et al. Among authors: marchand a. Mov Disord. 2022 Aug;37(8):1761-1767. doi: 10.1002/mds.29124. Epub 2022 Jun 16. Mov Disord. 2022. PMID: 35708213 Free PMC article.
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.
Marchand A, Sarchione A, Athanasopoulos PS, Roy HB, Goveas L, Magnez R, Drouyer M, Emanuele M, Ho FY, Liberelle M, Melnyk P, Lebègue N, Thuru X, Nichols RJ, Greggio E, Kortholt A, Galli T, Chartier-Harlin MC, Taymans JM. Marchand A, et al. Cells. 2022 Mar 17;11(6):1018. doi: 10.3390/cells11061018. Cells. 2022. PMID: 35326469 Free PMC article.
Impact of adjuvant radiation therapy on survival and recurrence in patients with stage I-III Merkel cell carcinoma: A retrospective study of 312 patients.
Pottier C, Marchand A, Kervarrec T, Le Corre Y, Nardin C, Aubin F, Wierzbicka-Hainaut E, Cassecuel J, Dreno B, Bens G, Beneton N, Legoupil D, Dinulescu M, Saiag P, Fily-Blom A, Samimi M. Pottier C, et al. Among authors: marchand a. J Am Acad Dermatol. 2023 Oct;89(4):824-826. doi: 10.1016/j.jaad.2023.04.071. Epub 2023 Jun 10. J Am Acad Dermatol. 2023. PMID: 37307995 No abstract available.
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkers.
Taymans JM, Mutez E, Sibran W, Vandewynckel L, Deldycke C, Bleuse S, Marchand A, Sarchione A, Leghay C, Kreisler A, Simonin C, Koprich J, Baille G, Defebvre L, Dujardin K, Destée A, Chartier-Harlin MC. Taymans JM, et al. Among authors: marchand a. NPJ Parkinsons Dis. 2023 Feb 7;9(1):21. doi: 10.1038/s41531-023-00445-9. NPJ Parkinsons Dis. 2023. PMID: 36750568 Free PMC article.
13 results